ITRM Iterum Therapeutics plcStock Price & Overview
$1.57
Charts
Quant Ranking
ITRM Analysis
ITRM News
Latest Headlines
Ratings Summary
People Also Follow
Similar to ITRM
ETFs Holding ITRM
ITRM Company Profile
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
ITRM Revenue
ITRM Earnings Per Share
Earnings Estimates
Earnings Revisions
Profitability
Momentum
Capital Structure
Dividends
ITRM Ownership
ITRM Peers
Risk
Technicals
ITRM Transcripts
Investor Presentations
ITRM SEC Filings
Press Releases
ITRM Income Statement
ITRM Balance Sheet
ITRM Cash Flow Statement
ITRM Long Term Solvency
Discover More
You may be interested in: